Human Milk Oligosaccharides (HMOs) Post-market Study on Infants

NACompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

December 31, 2018

Conditions
GrowthToleranceAdverse EventDisorder of IntestineDisorder Lung
Interventions
OTHER

HMO-supplemented infant formula

Starter Infant Formula supplemented with 1.5g/L of Human Milk Oligosaccharides

Trial Locations (6)

15011

Hospital Maternal MH Belén, A Coruña

28034

Ruber Internacional Clinic, Madrid

35005

Vitha Santa Catalina Hospital, Las Palmas de Gran Canaria

46021

Casa de la Salud, Hospital, Valencia

08028

Universitary Hospital Quirón-Dexeus, Barcelona

Unknown

Hispalense Group, Seville

Sponsors
All Listed Sponsors
collaborator

Puerta de Hierro University Hospital

OTHER

collaborator

University of Navarrra Hospital (Clinica Universitaria)

OTHER

collaborator

Grupo Pulso

INDUSTRY

collaborator

Casa de la Salud Hospital

UNKNOWN

collaborator

Vitha Santa Catalina Hospital

UNKNOWN

collaborator

Quirón-Dexeus Universitary Hospital

UNKNOWN

collaborator

Hospital Ruber Internacional

OTHER

collaborator

Grupo Hispalense de Pediatría Hospital

UNKNOWN

collaborator

MH Belén Maternal Hospital

UNKNOWN

lead

Société des Produits Nestlé (SPN)

INDUSTRY